243, Novartis Investigational Site — Colorado Springs, Colorado

243, Novartis Investigational Site is a clinical research site located in Colorado Springs, Colorado, United States 80902.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

243, Novartis Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Colorado Springs

Browse all research sites in Colorado · View every site in Colorado Springs

• University of Colorado Health Medical Group
• UCH-MHS Memorial Hospital North
• Memorial Hospital: University of Colorado Health
• University of Colorado-MHS (UCHealth Memorial)
• University of Colorado Cancer Center
• Penrose Cancer Center at Penrose Hospital
• UCHealth Memorial Hospital North
• UCHealth Memorial Hospital Central
• UC Health Memorial Hospital Center
• Colorado Cardiac Alliance -- Memorial Hospital
• UC Health-Memorial Hospital
• UCHealth Memorial Central Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 243, Novartis Investigational Site?

243, Novartis Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 243, Novartis Investigational Site conducted?

243, Novartis Investigational Site has 1 clinical trials on record. Their work covers Influenza Virus.

Is 243, Novartis Investigational Site accredited by Crixeo Clinical Trials?

243, Novartis Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 243, Novartis Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.